"
Home Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Page43 Page44 Page45 Page46 Page47 Page48 Page49 Page50 Page51 Page52 Page53 Page54 Page55 Page56 Page57 Page58 Page59 Page60 Page61 Page62 Page63 Page64 Page65 Page66 Page67 Page68 Page69 Page70 Page71 Page72 Page73 Page74 Page75 Page76 Page77 Page78 Page79 Page80 Page81 Page82 Page83 Page84 Page85 Page86 Page87 Page88 Page89 Page90 Page91 Page92 Page93 Page94 Page95 Page96 Page97 Page98 Page99 Page100 Page101 Page102 Page103 Page104 Page105 Page106 Page107 Page108 Page109 Page110 Page111 Page112 Page113 Page114 Page115 Page116 Page117 Page118 Page119 Page120 Page121 Page122 Page123 Page124 Page125 Page126 Page127 Page128 Page129 Page130 Page131

Antiemetic Drugs: Classification, Mechanism, Therapeutic Uses, and Adverse Effects


Classification of Antiemetic Drugs

  • 5-HT3 (Serotonin) Antagonists: Ondansetron, Granisetron
  • Dopamine (D2) Antagonists: Metoclopramide, Domperidone, Prochlorperazine
  • Antihistamines (H1 Antagonists): Dimenhydrinate, Meclizine, Promethazine
  • Anticholinergics (Muscarinic Antagonists): Scopolamine
  • NK1 (Neurokinin-1) Receptor Antagonists: Aprepitant
  • Cannabinoids: Dronabinol, Nabilone
  • Benzodiazepines: Lorazepam

Mechanism of Action of Antiemetic Drugs

  • 5-HT3 Antagonists: Block serotonin receptors in the GI tract and chemoreceptor trigger zone (CTZ), reducing nausea and vomiting signals.
  • Dopamine (D2) Antagonists: Block dopamine receptors in the CTZ, preventing emetic signals from reaching the vomiting center.
  • Antihistamines (H1 Antagonists): Block histamine receptors in the vestibular system and CTZ, effective for motion sickness.
  • Anticholinergics (Muscarinic Antagonists): Inhibit muscarinic receptors in the vestibular system, reducing motion-induced nausea.
  • NK1 Receptor Antagonists: Block neurokinin-1 receptors, preventing substance P from activating the vomiting reflex.
  • Cannabinoids: Activate cannabinoid receptors, reducing nausea signals within the central nervous system.
  • Benzodiazepines: Enhance GABA action, reducing anxiety and chemotherapy-related nausea.

Therapeutic Uses of Antiemetic Drugs

  • 5-HT3 Antagonists: Used in chemotherapy-induced nausea, postoperative nausea, and radiation therapy-induced nausea.
  • Dopamine (D2) Antagonists: Effective for GI-related nausea, chemotherapy, and migraine.
  • Antihistamines (H1 Antagonists): Primarily for motion sickness, vertigo, and mild pregnancy-related nausea.
  • Anticholinergics (Muscarinic Antagonists): Effective in preventing motion sickness.
  • NK1 Receptor Antagonists: Used with 5-HT3 antagonists and corticosteroids in chemotherapy-induced nausea.
  • Cannabinoids: For refractory chemotherapy-induced nausea and appetite stimulation.
  • Benzodiazepines: For anticipatory nausea in chemotherapy and as adjunctive therapy.

Adverse Effects of Antiemetic Drugs

  • 5-HT3 Antagonists: Headache, constipation, QT interval prolongation.
  • Dopamine (D2) Antagonists: Extrapyramidal symptoms, sedation, hypotension.
  • Antihistamines (H1 Antagonists): Sedation, dry mouth, dizziness, urinary retention.
  • Anticholinergics (Muscarinic Antagonists): Dry mouth, blurred vision, urinary retention, drowsiness.
  • NK1 Receptor Antagonists: Fatigue, diarrhea, hiccups.
  • Cannabinoids: Euphoria, dizziness, dysphoria, tachycardia.
  • Benzodiazepines: Sedation, dependency, cognitive impairment.

© 2024 Easy Notes on Pharmacology.
Privacy Policy | Contact Us Subscribe to our RSS feed